Pharmaceutical

Subscribe

Britain''s government competition watchdog began an investigation into the supply of medicines across the country after Pfizer Inc. signed a deal to sell its prescription drugs through a single wholesaler,

Teva Pharmaceutical Industries Ltd., the world''s largest maker of generic drugs, said it plans to appeal a U.S. judge''s decision to uphold patents protecting Pfizer Inc.''s pain reliever Celebrex, the

The Associated Press reports that Pfizer Inc. chairman and CEO Jeffrey B. Kindler received compensation last year that the company valued at $11.4 million, according to a regulatory filing on

The Associated Press reports that attorneys for Mylan Laboratories Inc. have said the generic drug maker will appeal a ruling barring it from marketing a generic version of Pfizer Inc.''s

The Associated Press reports that drug maker Bristol-Myers Squibb Co. has purchased an 89-acre site to build a new plant for manufacturing biological compounds.The company said the new Devens, Mass.

The Associated Press reports that U.S. drug maker Pfizer Inc. recently lost a minor legal battle with Chinese rivals over rights to names for its popular anti-impotence drug Viagra, a

According to the Associated Press, Merck & Co. plans to invest about $100 million to expand its vaccine manufacturing facility in Durham if approved by county commissioners. The planned 115,000-square-foot

Two pharmaceutical drug distributors pleaded guilty to taking part in a $42 million conspiracy to illegally import and sell the cholesterol reduction drug Lipitor and other medicines, the Associated Press

Spectrum Pharmaceuticals Inc. has settled a patent dispute with GlaxoSmithKline PLC related to its generic version of Glaxo''s Imitrex injection, according to the Associated Press. Under terms of the settlement,

Abbott Laboratories Inc. said it will acquire Kos Pharmaceuticals Inc. for $3.7 billion to boost its presence in the lucrative cholesterol-treatment market, Reuters reports. The agreement provides for Abbott to